Abiratas 500mg Tablet Specification
- Pacakaging (Quantity Per Box)
- 60
- Medicine Type
- Anti Cancer
- Expiration Date
- 2028 Years
- Indication
- Treatment of prostate cancer.
- Salt Composition
- abiraterone acetate
- Molecular Formula
- abiraterone acetate
- Usage
- Treatment of prostate cancer.
- Storage
- This medicine does not require any particular storage condition.
Abiratas 500mg Tablet Trade Information
- Minimum Order Quantity
- 1 Piece
About Abiratas 500mg Tablet
Abiratas 500mg Tablet contains Abiraterone Acetate, a targeted anticancer medication used in adult men for the treatment of advanced prostate cancer that has spread to other parts of the body. It works by reducing the production of testosterone and other androgens that promote the growth of prostate cancer cells, helping to slow disease progression and improve treatment outcomes. Abiratas 500mg Tablet is usually prescribed along with a corticosteroid to minimize treatment-related side effects and may also be used in combination with hormone-lowering therapy in certain stages of prostate cancer. This medication is not intended for use in women or children. Before starting treatment, patients should inform their healthcare provider about any history of liver disease, high blood pressure, heart conditions, low potassium levels, diabetes, allergies, or other significant medical problems. Since the tablet contains lactose and sodium, individuals with lactose intolerance or those following a sodium-restricted diet should seek medical advice before use. Common side effects may include swelling in the feet or legs, high blood pressure, diarrhea, reduced red blood cell counts, fatigue, and decreased libido. Patients should also disclose all prescription medications, over-the-counter drugs, herbal supplements, and vitamins they are taking to help prevent potential drug interactions. Effective contraception is recommended during treatment, and Abiratas 500mg Tablet should not be used together with Radium-223 (Ra-223), a treatment for prostate cancer, unless specifically advised by a healthcare professional. Regular monitoring during therapy helps ensure the safe and effective management of prostate cancer.